STOCK TITAN

Adlai Nortye (Nasdaq: ANL) revises selling shareholders for 98.6M registered shares

(Neutral)
(Neutral)
Form Type
424B7

Rhea-AI Filing Summary

Adlai Nortye Ltd. updates its resale registration for up to 98,577,627 Class A ordinary shares, represented by 32,859,209 ADSs, by changing how certain shares are attributed among selling shareholders. The change reflects that SILV Fund, Ltd. is now listed as the selling shareholder for 2,307,690 Class A ordinary shares originally shown as held under the February 2026 Private Placement by Point72 Associates, LLC. Point72 continues as a selling shareholder for 2,943,396 Class A ordinary shares from the April 2026 Private Placement. The total number of Class A ordinary shares registered for resale remains unchanged, based on 218,578,430 Class A ordinary shares outstanding as of April 21, 2026. The company’s ADSs trade on Nasdaq under the symbol ANL, and the last reported sale price on July 17, 2026 was US$11.53 per ADS.

Positive

  • None.

Negative

  • None.
Registered ordinary shares 98,577,627 Class A ordinary shares Maximum number of Class A ordinary shares registered for resale
Registered ADSs 32,859,209 ADSs ADSs representing the registered Class A ordinary shares, 3 shares per ADS
Point72 registered shares 2,943,396 Class A ordinary shares Shares attributed to Point72 Associates, LLC under the April 2026 Private Placement
SILV Fund registered shares 2,307,690 Class A ordinary shares Shares attributed to SILV Fund, Ltd. under the February 2026 Private Placement
SILV Fund post-offering ownership 1.06% Percentage of Class A ordinary shares owned after the offering
Shares outstanding 218,578,430 Class A ordinary shares Shares outstanding as of April 21, 2026, used for ownership percentages
Recent ADS price US$11.53 per ADS Last reported sale price on Nasdaq on July 17, 2026
Point72 post-offering ownership 1.35% Percentage of Class A ordinary shares owned after the offering
prospectus supplement regulatory
"This prospectus supplement amends and supplements information contained or incorporated"
A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.
Selling Shareholders regulatory
"relating to the resale from time to time by the selling shareholders"
Shareholders who are offering some or all of their shares for sale in a market transaction or as part of an offering; they can be founders, early investors, employees, or other holders deciding to convert ownership into cash. Investors care because selling shareholders can change the ownership mix, increase the number of shares available to trade, and signal insiders’ confidence or need for liquidity—like a large owner putting a big parcel on the market, which can affect price and voting control.
American Depositary Shares financial
"represented by 32,859,209 American Depositary Shares, or ADSs, each ADS representing"
American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.
Private Placement financial
"previously identified under the February 2026 Private Placement in the prospectus"
A private placement is a sale of securities directly to a selected group of investors, typically institutions or accredited investors, instead of through a public offering. It lets a company raise money faster and with fewer regulatory steps; for existing shareholders it matters because the newly issued shares, often sold at a discount, increase the share count and can dilute their ownership.
Offering Type secondary

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What does Adlai Nortye (ANL) change in Prospectus Supplement No. 1?

Adlai Nortye reassigns certain resale shares from Point72 Associates, LLC to SILV Fund, Ltd. as a selling shareholder. The update is limited to attribution and does not alter the total shares registered for resale.

How many Adlai Nortye (ANL) shares are registered for resale under this prospectus?

The prospectus covers up to 98,577,627 Class A ordinary shares, represented by 32,859,209 ADSs. Each ADS equals three Class A ordinary shares, and this supplement does not change the overall registered amount.

What holdings do Point72 and SILV Fund have in Adlai Nortye (ANL) under the supplement?

Point72 Associates, LLC is listed for 2,943,396 Class A ordinary shares from the April 2026 Private Placement. SILV Fund, Ltd. is listed for 2,307,690 Class A ordinary shares from the February 2026 Private Placement, reflecting a transfer of those shares.

What percentage of Adlai Nortye (ANL) does SILV Fund’s registered stake represent?

SILV Fund, Ltd. is shown with 2,307,690 Class A ordinary shares, representing 1.06% ownership after the offering. Percentages are based on 218,578,430 Class A ordinary shares outstanding as of April 21, 2026.

What is the recent Nasdaq trading price for Adlai Nortye (ANL) ADSs?

On July 17, 2026, Adlai Nortye’s ADSs last traded at US$11.53 per ADS on Nasdaq. Each ADS represents three Class A ordinary shares, providing a reference point for the registered resale shares.

Does this Adlai Nortye (ANL) supplement change the total resale registration size?

No. The supplement states it does not increase or modify the number of Class A ordinary shares registered for resale. It only updates the selling shareholder list to add SILV Fund for certain transferred shares.

PROSPECTUS SUPPLEMENT NO. 1

(To Prospectus dated April 28, 2026)

 

Filed Pursuant to Rule 424(b)(7)

Registration No. 333-294173

 

 

ADLAI NORTYE LTD.

 

Up to 98,577,627 Class A Ordinary Shares
(represented by 32,859,209 American Depositary Shares)
Offered by the Selling Shareholders

 

This prospectus supplement (this “prospectus supplement”) amends and supplements information contained or incorporated by reference in the prospectus dated April 28, 2026 (the “prospectus”) relating to the resale from time to time by the selling shareholders identified therein (the “Selling Shareholders”) of up to 98,577,627 Class A ordinary shares, par value US$0.0001 per share, represented by 32,859,209 American Depositary Shares, or ADSs, each ADS representing three Class A ordinary shares, of Adlai Nortye Ltd. (the “Company,” “we,” “us” or “our”).

 

The purpose of this prospectus supplement is solely to supplement and amend the “Selling Shareholders” section commencing on page 40 of the prospectus to reflect that SILV Fund, Ltd. (“SILV Fund”) should be identified as the Selling Shareholder with respect to certain of the Class A ordinary shares previously identified in the prospectus as held by Point72 Associates, LLC (“Point72”). For the avoidance of doubt, this prospectus supplement does not increase or otherwise modify the number of Class A ordinary shares registered for resale under the prospectus.

 

This prospectus supplement should be read in conjunction with, and is qualified by reference to, the prospectus, except to the extent that information contained herein supersedes the information contained or incorporated by reference in the prospectus. This prospectus supplement may only be delivered or utilized in connection with the prospectus and any future amendments or supplements thereto.

 

Our ADSs are listed on The Nasdaq Stock Market under the symbol “ANL”. On July 17, 2026, the last reported sale price of the ADSs on Nasdaq was US$11.53 per ADS.

 

Investing in our securities involves risks. See “Risk Factors” beginning on page 16 of the prospectus and in our filings with the Securities and Exchange Commission incorporated by reference into the prospectus.

 

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of the prospectus or this prospectus supplement. Any representation to the contrary is a criminal offense.

 

The date of this prospectus supplement is July 20, 2026.

 

 

 

Selling Shareholders

 

The following information amends and supplements the information that appears under the heading “Selling Shareholders” beginning on page 40 of the prospectus. Capitalized terms used herein but not defined have the meanings ascribed to such terms in the prospectus.

 

Point72, a Selling Shareholder identified in the prospectus, has informed us that an aggregate of 2,307,690 Class A ordinary shares previously identified under the February 2026 Private Placement in the prospectus as held by Point72 were transferred to SILV Fund. Point 72 remains as the Selling Shareholder of 2,943,396 Class A ordinary shares previously identified under the April 2026 Private Placement. Accordingly, the disclosure in the prospectus is hereby supplemented and amended to add SILV Fund as a Selling Shareholder with respect to such transferred shares. This prospectus supplement does not change the aggregate number of Class A ordinary shares being offered for resale under the prospectus.

 

The percentages of Class A ordinary shares owned after the offering by the Selling Shareholders below are based on 218,578,430 Class A ordinary shares outstanding as of April 21, 2026. The following table reflects the applicable amended information with respect to SILV Fund. All information regarding the Selling Shareholders identified below was provided by or on behalf of such Selling Shareholders.

 

Name of Selling Shareholders  Number of
Class A
Ordinary Shares
Being Offered
   Percentage
Ownership
   Private Placement
Point72 Associates, LLC(11)   2,943,396    1.35%  April 2026 Private Placement

SILV Fund, Ltd.(39)

   2,307,690    1.06%  February 2026 Private Placement

 

(11)Represents an aggregate of 2,943,396 Class A ordinary shares acquired by Point72 Associates, LLC in February 2026 Private Placement and April 2026 Private Placement, respectively. The registered address of Point72 Associates, LLC is c/o Point72 Asset Management, 72 Cumming Point Road, Stamford, CT 06902.

 

(39)Represents 2,307,690 Class A ordinary shares held by SILV Fund, Ltd. Sirenia Capital Management LP (“Sirenia”) is the investment manager of SILV Fund, Ltd. and as such has investment and voting power with respect to the securities held by SILV Fund, Ltd. Sirenia Capital Management GP LLC (“Sirenia GP”) is the general partner of Sirenia. Alex Silverstein is the managing member of Sirenia GP. Each of SILV Fund, Ltd., Sirenia GP and Mr. Silverstein disclaims beneficial ownership over such securities. The address for SILV Fund, Ltd. is c/o Sirenia Capital Management LP, 1674 Meridian Avenue, Suite 320, Miami Beach, FL 33139.

 

All of the other portions of the prospectus remain unchanged.